Long-Term Sulfonylurea Use and Impaired Awareness of Hypoglycemia Among Patients With Type 2 Diabetes in Taiwan

被引:0
|
作者
Cheng, Hsiang-Ju [1 ]
Weng, Siou-Huei [2 ,3 ]
Wu, Jia-Ling [2 ]
Yeh, Shu-Tin [4 ]
Chen, Hua-Fen [4 ,5 ,6 ]
Novida, Hermina [7 ]
Ou, Huang-Tz [8 ,9 ,10 ]
Li, Chung-Yi [2 ,11 ,12 ]
机构
[1] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Family Med, Tainan, Taiwan
[2] Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, 1 Univ Rd, Tainan 701, Taiwan
[3] Tainan City Govt, Publ Hlth Bur, Dis Control Sect Div, Tainan, Taiwan
[4] Far Eastern Mem Hosp, Dept Endocrinol, New Taipei City, Taiwan
[5] Fu Jen Catholic Univ, Coll Med, Dept Med, New Taipei City, Taiwan
[6] Fu Jen Catholic Univ, Coll Med, Dept Publ Hlth, New Taipei City, Taiwan
[7] Univ Airlangga, Fac Med, Dept Internal Med, Div Endocrine Metab & Diabet, Surabaya, Indonesia
[8] Natl Cheng Kung Univ, Inst Clin Pharm & Pharmaceut Sci, Coll Med, Tainan, Taiwan
[9] Natl Cheng Kung Univ, Coll Med, Dept Pharm, Tainan, Taiwan
[10] Natl Cheng Kung Univ Hosp, Dept Pharm, Tainan, Taiwan
[11] China Med Univ, Coll Publ Hlth, Dept Publ Hlth, Taichung, Taiwan
[12] Asia Univ, Coll Med & Hlth Sci, Dept Healthcare Adm, Taichung, Taiwan
关键词
hypoglycemia; type; 2; diabetes; sulfonylurea; insulin; hypoglycemic agents; glycemic control; risk factors; diabetes complications; primary care; MECHANISMS; FREQUENCY;
D O I
10.1370/afm.3129
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
PURPOSE We undertook a study to investigate the relationship between duration of medication use and prevalence of impaired awareness of hypoglycemia (IAH) among patients with insulin-treated or sulfonylurea-treated type 2 diabetes in Taiwan. METHODS A total of 898 patients (41.0% insulin users, 65.1% sulfonylurea users; mean [SD] age = 59.9 [12.3] years, 50.7% female) were enrolled in pharmacies, clinics, and health bureaus of Tainan City, Taiwan. Presence of IAH was determined with Chinese versions of the Gold questionnaire (Gold-TW) and Clarke questionnaire (Clarke-TW). Sociodemographics, disease and treatment histories, diabetes-related medical care, and health status were collected. We used multiple logistic regression models to assess the relationship between duration of medication use and IAH. RESULTS Overall IAH prevalence was 41.0% (Gold-TW) and 28.2% (Clarke-TW) among insulin users, and 65.3% (Gold-TW) and 51.3% (Clarke-TW) among sulfonylurea users. Prevalence increased with the duration of sulfonylurea use, whereas it decreased with the duration of insulin use. After controlling for potential confounders, 5 or more years of sulfonylurea use was significantly associated with 3.50-fold (95% CI, 2.39-5.13) and 3.06-fold (95% CI, 2.114.44) increases in the odds of IAH based on the Gold-TW and Clarke-TW criteria, respectively. On the other hand, regular blood glucose testing and retinal examinations were associated with reduced odds in both insulin users and sulfonylurea users. CONCLUSIONS The prevalence of IAH was high among patients using sulfonylureas long term, but the odds of this complication were attenuated for those who received regular diabetes-related medical care. Our study suggests that long-term sulfonylurea use and irregular follow-up increase risk for IAH. Further prospective studies are needed to confirm the observed associations. Ann Fam Med 2024;22:309-316. https://doi.org/10.1370/afm.3129 Annals Early Access article
引用
收藏
页码:309 / 316
页数:8
相关论文
共 50 条
  • [41] The decision not to drive during hypoglycemia in patients with type 1 and type 2 diabetes according to hypoglycemia awareness
    Stork, Alexander D. M.
    van Haeften, Timon W.
    Veneman, Thiemo F.
    DIABETES CARE, 2007, 30 (11) : 2822 - 2826
  • [42] Real life evidence that impaired awareness of hypoglycemia persists for years in patients with type 1 diabetes
    Zekarias, K.
    Kumar, A.
    Moheet, A.
    Seaquist, E.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2018, 32 (12) : 1097 - 1099
  • [43] Structural Gray and White Matter Differences in Patients With Type 1 Diabetes and Impaired Awareness of Hypoglycemia
    Stantonyonge, Nicole
    Sampedro, Frederic
    Mendez, Jorge
    Martinez-Horta, Saul
    Chico, Ana
    Gomez-Anson, Beatriz
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (02): : 450 - 458
  • [44] Glycemic response to exercise among obese patients with type 2 diabetes: Impact of sulfonylurea use
    Dasgupta, K
    Grover, S
    Lowensteyn, I
    Rahme, E
    DIABETES, 2004, 53 : A460 - A460
  • [45] Effect of Hypoglycemia on Heart Rate Variability in People with Type 1 Diabetes and Impaired Awareness of Hypoglycemia
    Koeneman, Mats
    Bekkink, Marleen Olde
    van Meijel, Lian
    Bredie, Sebastian
    de Galan, Bastiaan
    JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2022, 16 (05): : 1144 - 1149
  • [46] Impact of HbA1c and Sulfonylurea Use on Hypoglycemia in Type 2 Diabetes Mellitus
    Bron, Morgan
    Clements, Karen
    Taylor, Doug
    Emptage, Nicholas
    Hudgens, Stacie
    Dabbous, Omar
    DIABETES, 2010, 59 : A207 - A208
  • [47] LONG-TERM USE OF COLESTIMIDE IS EFFECTIVE AGAINST HYPERGLYCEMIA AND OVERWEIGHT IN PATIENTS WITH TYPE 2 DIABETES
    Kurioka, S.
    Fukuma, H.
    Yoshimoto, K.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2013, 15 : A122 - A122
  • [48] DIABETES CARE AMONG RESIDENTS OF LONG-TERM CARE FACILITIES IN TAIWAN
    Hwang, S.
    Chen, L.
    Lin, M.
    Lai, H.
    GERONTOLOGIST, 2008, 48 : 304 - 304
  • [49] Long-Term Use of Colestimide Is Effective Against Hyperglycemia and Overweight in Patients with Type 2 Diabetes
    Kurioka, Soichi
    DIABETES, 2011, 60 : A299 - A299
  • [50] New onset diabetes among parkinsonian patients on long-term clozapine use
    Fernandez, HH
    Friedman, JH
    Factor, SA
    Molho, ES
    Coskun, JD
    Lansang, MC
    MOVEMENT DISORDERS, 2002, 17 : S47 - S47